XML 15 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Statements of Comprehensive Loss - ILS (₪)
₪ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Profit or loss [abstract]      
Revenues ₪ 756 ₪ 483 ₪ 1,683
Cost of revenues (532) (398) (1,069)
Gross profit 224 85 614
Research and development expenses, net (9,840) (8,897) (19,397)
Selling and marketing expenses, net (2,425) (2,406) (4,796)
General and administrative expenses (4,742) (4,460) (9,673)
Operating loss (16,783) (15,678) (33,252)
Financing expenses (3,031) (1,242) (2,785)
Financing income 3,695 636 1,099
Financing income (expenses), net 664 (606) (1,686)
Loss for the period (16,119) (16,284) (34,938)
Comprehensive loss for the period ₪ (16,119) ₪ (16,284) ₪ (34,938)
Basic and diluted loss per share:      
Basic loss per share (in New Shekels per share) ₪ (0.01) ₪ (0.21) ₪ (0.3)
Diluted loss per share (in New Shekels per share) ₪ (0.01) ₪ (0.21) ₪ (0.3)
Weighted average of number of shares used to calculate the basic loss per share (in Shares) 1,217,701,006 79,171,297 117,908,475
Weighted average of number of shares used to calculate the diluted loss per share (in Shares) 1,217,701,006 79,171,297 117,908,475